University of South China   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Hengyang China (2000)

Organization Overview

First Clinical Trial
2011
NCT01503801
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Hunan Children's Hospital | The First Affiliated Hospital of University of South China | The second Affiliated Hospital of University of Soth China | The Second Affiliated Hospital of University of South China | The Second Hospital University of South China

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bronchopulmonary Dysplasia (Phase 3)

Carcinoma (Phase 3)

Carcinoma, Hepatocellular (Phase 3)

Dwarfism, Pituitary (Phase 4)

Endocrine System Diseases (Phase 4)

Fibrosis (Phase 1)

Herpangina (Phase 4)

Liver Cirrhosis (Phase 1)

Pneumoconiosis (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 14
  • # of Trial APIs: 19